Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Achieve Life Sciences Inc (ACHV).
Achieve Life Sciences, Inc. has initiated a Registered Direct Offering and concurrent Private Placement to sell over 13 million shares and warrants, aiming to raise approximately $56.2 million in net proceeds. These funds are earmarked for the clinical development of cytisinicline, including the ORCA-OL clinical trial, and other corporate purposes. The offering is supported by a shelf registration statement and prospectus, with additional potential proceeds of $64.2 million if all Private Placement Warrants are exercised, potentially funding the company’s operations into 2026.
See more data about ACHV stock on TipRanks’ Stock Analysis page.